Publication:
Letter re: reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: a single-arm, phase 2 trial

Simple item page
dc.contributor.coauthorTopkan E.
dc.contributor.coauthorSomay E.
dc.contributor.coauthorPehlivan B.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorSelek, Uğur
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-12-29T09:37:17Z
dc.date.issued2023
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume200
dc.identifier.doi10.1016/j.ejca.2023.113459
dc.identifier.eissn1879-0852
dc.identifier.issn0959-8049
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85185492666
dc.identifier.urihttps://doi.org/10.1016/j.ejca.2023.113459
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22302
dc.identifier.wos1188825600001
dc.keywordsDNA
dc.keywordsDNA viral
dc.keywordsEpstein-barr virus infections
dc.keywordsHerpesvirus 4
dc.keywordsHumans
dc.keywordsNasopharyngeal carcinoma
dc.keywordsNasopharyngeal neoplasms
dc.language.isoeng
dc.publisherELSEVIER
dc.relation.ispartofEuropean Journal of Cancer
dc.subjectOncology
dc.titleLetter re: reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: a single-arm, phase 2 trial
dc.typeLetter
dspace.entity.typePublication
local.contributor.kuauthorSelek, Uğur
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext